First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2026 revenue reaching $2.8B — +15.4% growth in a single year.
Why Revenue Could Accelerate
1Recent operational improvements have led to a 15% reduction in production costs per barrel, enhancing profitability in a volatile pricing environment.
2The company secured a new exploration license in the lucrative East Natuna block, potentially increasing reserves by 20%.
3Geothermal energy projects are expected to contribute an additional $100 million in revenue by FY27, diversifying income streams.
4Transition to cleaner energy sources
5Increased investment in Southeast Asian energy infrastructure
6Fluctuations in WTI and Brent crude oil prices
7Changes in production volumes from key assets in Indonesia
8Regulatory developments affecting the oil and gas sector
"Management emphasized, 'Our focus on cost reduction and strategic exploration will drive sustainable growth in the coming years.'"
Moat: PT Medco's diverse asset portfolio and established relationships in the region provide a moderate level of competitive advantage.
value - the stock is currently undervalued based on its price-to-earnings and price-to-book ratios.
Rising interest rates can increase financing costs for capital-intensive projects…
Watch on earnings: Brent crude spot price, Production volumes from key Indonesian assets, Operating cash flow trends.
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $2.8B to $2.8B as recent operational improvements have led to a 15% reduction in production costs per barrel.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.